Colic medication and apparent life-threatening events

R A Hardoin1, J A Henslee, C P Christenson

  • 1Southwest SIDS Research Institute, Lake Jackson, Texas 77566.

Insights

Colic medications containing Dramamine and Donnatal may cause cardiorespiratory instability and GER in infants. Further evaluation is needed to confirm if these common infant colic treatments contribute to apparent life-threatening events (ALTE).

Area of Science:

  • Pediatric Medicine
  • Neonatology
  • Clinical Pharmacology

Background:

  • Apparent life-threatening events (ALTE) in infants often lack clear etiology.
  • Infants experiencing ALTE were previously treated for colic with a mixture of dimenhydrinate (Dramamine) and Donnatal.

Purpose of the Study:

  • To investigate the potential link between colic medication and cardiorespiratory abnormalities and gastroesophageal reflux (GER) in infants presenting with ALTE.

Main Methods:

  • Case series evaluation of eight infants with ALTE histories.
  • Polygraphic evaluation conducted after withdrawal of dimenhydrinate/Donnatal colic medication.
  • Assessment for cardiorespiratory abnormalities and significant gastroesophageal reflux (GER).

Main Results:

  • All eight infants exhibited cardiorespiratory abnormalities upon polygraphic evaluation.
  • Significant gastroesophageal reflux (GER) was documented in four of the eight infants.
  • No underlying cause for ALTE was identified through comprehensive initial work-up.

Conclusions:

  • The study suggests a potential contribution of dimenhydrinate/Donnatal colic medication to cardiorespiratory instability and GER in susceptible infants.
  • Further research is warranted to confirm the role of this common colic treatment in infant ALTE.

Related Concept Videos

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...